It emphasizes the sensitivity of different breast cancer subtypes to ferroptosis as a driving force in the current research landscape and highlights the pivotal role of GPX4 in the regulatory mechanisms of ferroptosis in breast cancer as a key focus. The gene discussed is GPX4; the disease is breast carcinoma.